Albemarle Slips 1.71% as Shares Extend Monthly Loss
The specialty chemicals company's shares fell more than the broader market, while consensus forecasts point to higher quarterly sales and earnings.
Makkler Newsroom · Oct 1, 01:43 AM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $135.24 (+44.6%)
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO